FDA Warning: Weight Loss Drug Belviq May Increase Cancer Risk

The FDA has released a public alert regarding the safety of weight loss drug lorcaserin after a clinical trial assessing safety of the drug showed that it may increase the risk of cancer.

Read the full post at Forbes - Healthcare
Vote This Post DownVote This Post Up (No Ratings Yet)
Explore the Archive